BioScience Health Innovations, Inc. Operating Income Loss

• BioScience Health Innovations, Inc. showed an increase of +726.5% in Operating Income Loss from 2024 to 2025.
• This data is from BioScience Health Innovations, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2020 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2020 to 2025), BioScience Health Innovations, Inc.'s Operating Income Loss has grown by 9,460.2%.
• Historical annual values: Fiscal year 2025: $719.1 thousand | Fiscal year 2024: $87.0 thousand | Fiscal year 2023: -$251.5 thousand | Fiscal year 2022: -$170.5 thousand | Fiscal year 2022: -$91.9 thousand | Fiscal year 2021: -$25.6 thousand | Fiscal year 2020: -$7.7 thousand.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026